Detalles de la búsqueda
1.
Seven-plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi-Institutional Collaborative Cohort Study.
Cancer Sci
; 115(2): 611-622, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041484
2.
The multigene classifiers 95GC/42GC/155GC for precision medicine in ER-positive HER2-negative early breast cancer.
Cancer Sci
; 112(4): 1369-1375, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33544932
3.
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
Breast Cancer Res Treat
; 188(1): 107-115, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33730265
4.
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores.
Breast Cancer Res Treat
; 189(2): 455-461, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131830
5.
Development of Prediction Model Including MicroRNA Expression for Sentinel Lymph Node Metastasis in ER-Positive and HER2-Negative Breast Cancer.
Ann Surg Oncol
; 28(1): 310-319, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32583195
6.
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.
Breast Cancer Res
; 21(1): 88, 2019 08 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387614
7.
Prognostic value of tumor cell DNA content determined by flow cytometry using formalin-fixed paraffin-embedded breast cancer tissues.
Breast Cancer Res Treat
; 176(1): 75-85, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30949799
8.
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer.
Breast Cancer Res Treat
; 173(3): 533-543, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30361874
9.
Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC.
Breast Cancer Res Treat
; 174(3): 627-637, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30607631
10.
Mutational Analysis of AKT1 and PIK3CA in Intraductal Papillomas of the Breast with Special Reference to Cellular Components.
Am J Pathol
; 188(5): 1106-1112, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29454754
11.
Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 171(1): 33-41, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29728801
12.
Highly sensitive detection of ESR1 mutations in cell-free DNA from patients with metastatic breast cancer using molecular barcode sequencing.
Breast Cancer Res Treat
; 167(1): 49-58, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28905136
13.
Endocrine sensitivity of estrogen receptor-positive breast cancer is negatively correlated with aspartate-ß-hydroxylase expression.
Cancer Sci
; 108(12): 2454-2461, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28985022
14.
Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing.
Breast Cancer Res Treat
; 163(2): 231-240, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28283903
15.
A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
Breast Cancer Res Treat
; 166(1): 55-68, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28702892
16.
Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer.
Breast Cancer Res Treat
; 157(1): 55-63, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27113738
17.
One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 23(1): 78-86, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26152274
18.
Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing.
Breast Cancer Res Treat
; 152(2): 305-12, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26093648
19.
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients.
Breast Cancer Res Treat
; 150(2): 299-307, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25736040
20.
BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
Cancer Sci
; 105(10): 1369-76, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25155055